Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 75, No. 3, 2005   

Free Abstract     Article (References)     Article (PDF 317 KB)     

Original Paper

Pharmacological Investigation of Trimetazidine in Models of Inflammation, Pain and Gastric Injury in Rodents
Omar M.E. Abdel-Salam, Siham El-Batran

Department of Pharmacology, National Research Centre, Cairo, Egypt

Address of Corresponding Author

Pharmacology 2005;75:122-132 (DOI: 10.1159/000088211)


 goto top of page Key Words

  • Trimetazidine
  • Nociception
  • Inflammation
  • Gastric mucosa

 goto top of page Abstract

The antinociceptive, anti-inflammatory and gastric effects of trimetazidine (2,3,4-trimethoxybenzyl-piperazine dihydrochloride), a novel anti-ischaemic compound, were evaluated in various animal models. In acute pain models, namely acetic acid-induced writhing, hot-plate assay, tail electric stimulation test, capsaicin-induced pain and the formalin test, trimetazidine (1.8-7.2 mg/kg, i.p.) showed marked antinociceptive effects. Trimetazidine did not produce any behavioural impairment as revealed by the mouse rotarod. The inhibition of writhing response by trimetazidine was reduced by yohimbine, theophylline (and to a certain extent by sulpiride) but not by prazosin, guanethidine, naloxone, atropine, propranolol, haloperidol, domperidone, clozapine, glibenclamide or caffeine. The carrageenan-evoked acute paw oedema was reduced by 19.2-21.2 and 17-18.6% by 3.6 and 7.2 mg/kg trimetazidine, respectively. The drug did not alter the oedema-suppressive effect of indomethacin or dexamethasone, but reduced that of rofecoxib. Trimetazidine at 7.2 mg/kg reduced immobility time in Porsolt's forced-swimming test by 28.9%. The acute gastric mucosal lesions evoked by indomethacin in the rat were inhibited in a dose-dependent manner by co-administration of trimetazidine. In anesthetized rats, trimetazidine potentiated the gastric acid secretory response. This study indicates that trimetazidine possesses antinociceptive and gastric protective properties. The antinociceptive properties of trimetazidine are likely to be centrally mediated, but do not involve opioid pathways.

Copyright © 2005 S. Karger AG, Basel


 goto top of page Author Contacts

Omar M.E. Abdel Salam, MD, PhD
Department of Pharmacology, National Research Centre
Tahrir St., Dokki, Cairo (Egypt)
Tel./Fax +20 3370931
E-Mail omasalam@hotmail.com


 goto top of page Article Information

Received: June 21, 2005
Accepted: July 25, 2005
Published online: September 9, 2005
Number of Print Pages : 11
Number of Figures : 13, Number of Tables : 1, Number of References : 38

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 16155371)
Download Citation
Cited In



This journal is part of the second subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel